COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 75 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $17,000 | -5.6% | 1,150 | 0.0% | 0.01% | -16.7% |
| Q4 2018 | $18,000 | +5.9% | 1,150 | 0.0% | 0.01% | +50.0% |
| Q3 2018 | $17,000 | -19.0% | 1,150 | 0.0% | 0.01% | -20.0% |
| Q2 2018 | $21,000 | -27.6% | 1,150 | 0.0% | 0.01% | -33.3% |
| Q1 2018 | $29,000 | +38.1% | 1,150 | 0.0% | 0.02% | +25.0% |
| Q4 2017 | $21,000 | +75.0% | 1,150 | 0.0% | 0.01% | +71.4% |
| Q3 2017 | $12,000 | -14.3% | 1,150 | 0.0% | 0.01% | -22.2% |
| Q2 2017 | $14,000 | +16.7% | 1,150 | 0.0% | 0.01% | +12.5% |
| Q1 2017 | $12,000 | -33.3% | 1,150 | 0.0% | 0.01% | -46.7% |
| Q4 2016 | $18,000 | -10.0% | 1,150 | 0.0% | 0.02% | -11.8% |
| Q3 2016 | $20,000 | +42.9% | 1,150 | 0.0% | 0.02% | +6.2% |
| Q2 2016 | $14,000 | -33.3% | 1,150 | 0.0% | 0.02% | -33.3% |
| Q1 2016 | $21,000 | +40.0% | 1,150 | +109.1% | 0.02% | +71.4% |
| Q4 2015 | $15,000 | – | 550 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 1,926,283 | $40,105,000 | 3.74% |
| Camber Capital Management LP | 4,000,000 | $83,280,000 | 2.20% |
| FRAZIER MANAGEMENT LLC | 943,666 | $19,647,000 | 1.76% |
| MANGROVE PARTNERS IM, LLC | 593,741 | $12,362,000 | 1.56% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 303,685 | $6,323,000 | 1.07% |
| Eventide Asset Management | 2,427,976 | $50,550,000 | 0.99% |
| Avidity Partners Management LP | 1,000,400 | $20,828,000 | 0.97% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,108,219 | $23,073,000 | 0.93% |
| Perceptive Advisors | 2,058,068 | $42,849,000 | 0.63% |
| Rock Springs Capital Management LP | 1,175,000 | $24,464,000 | 0.62% |